Tag: intravenous therapy solutions market

Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

What Is The Projected Valuation Of The Intravenous Therapy Solutions Market In The Coming Years?

In recent times, the market size for intravenous therapy solutions has experienced a significant increase. It is projected to escalate from $11.95 billion in 2024 to $13.17 billion in 2025, with a compound annual growth rate (CAGR) of 10.3%. Factors such as an elevated number of hospital admissions, a surge in surgical operations, a higher occurrence of dehydration, an increased prevalence of chronic illnesses, and better availability of healthcare infrastructure can explain the remarkable growth during the historic period.

Expectations are high for the intravenous therapy solutions market, with significant expansion anticipated in the coming years. Projected to reach a value of $19.33 billion by 2029 at a compound annual growth rate (CAGR) of 10.1%, the cause for this surge can be directly linked to various factors. These include an ageing population, the growth of home healthcare services, the escalating demand for fast rehydration treatments, an increase in gastrointestinal disorders, and the rising preference for single-use IV components. Key trends to look forward to within this period consist of advancements in IV drug delivery systems, a pivot towards home-based IV therapy, incorporation of smart infusion pumps, expansion in biologic and specialist drug infusions, and an increasing predilection for personalized IV nutritional therapy.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=25802&type=smp

What Drivers Are Accelerating Expansion Of The Intravenous Therapy Solutions Market?

The intravenous therapy solutions market is expected to see growth propelled by increased demand for minimally invasive therapies in the future. Minimally invasive therapies offer medical treatments that make minimal incisions or insertions into the body, often leading to a swifter recovery time and lessened complications. The rising popularity for these types of therapies can be credited to their ability to minimize postoperative pain, fostering improved patient comfort throughout recuperation and accelerating healing times. Intravenous therapy solutions enhance this process by ensuring the effective delivery of necessary fluids, medications, and nutrients directly into the patient’s bloodstream, thus optimizing patient care and speeding up recovery. In June 2024, data from the American Society of Plastic Surgeons, a non-profit organization based in the US, showed a 7%increase in minimally invasive procedures from the previous year in 2023, surpassing surgical procedures by 2%. Consequently, the escalating demand for minimally invasive therapies is prompting growth in the intravenous (IV) therapy solutions market.

How Is The Global Intravenous Therapy Solutions Market Broken Down By Segment?

The intravenous therapy solutions market covered in this report is segmented –

1) By Product Type: Crystalloids, Colloids, Blood Products, Other Product Types

2) By Application: Fluid And Electrolyte Imbalance, Nutritional Support, Medication Administration, Blood Transfusion, Other Applications

3) By End-User: Hospitals, Clinics, Ambulatory Surgical Centers, Home Care Settings, Other End-Users

Subsegments:

1) By Crystalloids: Normal Saline (0.9% Sodium Chloride), Half Normal Saline (0.45% Sodium Chloride), Lactated Ringer’s Solution, Dextrose Solutions, Hypertonic Saline

2) By Colloids: Albumin, Dextran, Hydroxyethyl Starch (HES), Gelatin

3) By Blood Products: Packed Red Blood Cells (PRBCs), Platelets, Fresh Frozen Plasma (FFP), Cryoprecipitate

4) By Other Product: Intravenous Immunoglobulins (IVIG), Parenteral Nutrition Solutions, Specialty Intravenous Drugs And Additives

Which Trends Are Likely To Redefine Growth Paths In The Intravenous Therapy Solutions Market?

Leading businesses in the intravenous therapy solutions market are making strides towards crafting innovative solutions, including ready-to-use drug infusion. These advancements aim towards improving treatment efficacy and cutting down time spent on preparation within healthcare environments. Ready-to-use drug infusion entails pre-mixed and pre-labeled IV medications already prepared in specified doses and packaging. This innovation negates the need for on-site medication compounding or dilution. A demonstration of this was seen in May 2024 when B. Braun Medical Inc., a manufacturing company based in the US, rolled out Levetiracetam in Sodium Chloride Injection, a ready-to-use intravenous anticonvulsant solution. Specifically designed to manage seizures, this product comes in standardized volumes and concentrations, removing the compounding or diluting processes in patient care. Levetiracetam IV is pre-mixed in a flexible package which ensures exact dosing, minimizes contamination risks, and offers convenience to medical practitioners in emergency and inpatient settings.

Which Firms Are Making The Biggest Impact In The Intravenous Therapy Solutions Market?

Major companies operating in the intravenous therapy solutions market are Pfizer Inc., Johnson & Johnson, Otsuka Pharmaceutical Co. Ltd., Baxter International Inc., Fresenius Kabi AG, Grifols S.A., Terumo Corporation, Dr. Reddy’s Laboratories Limited, Sichuan Kelun Pharmaceutical Co. Ltd., Teleflex Incorporated, Hikma Pharmaceuticals PLC, ICU Medical Inc., Biocon Limited, B. Braun Melsungen Aktiengesellschaft, JW Life Science Corporation, AdvaCare Pharma USA, Soxa Formulations & Research Pvt. Ltd., Vifor Pharma Management Ltd., Aetos Pharma Private Limited, LXIR Medilabs Private Limited

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/intravenous-therapy-solutions-global-market-report

Which Geographic Regions Are Creating Strong Demand In The Intravenous Therapy Solutions Market?

North America was the largest region in the intravenous therapy solutions market in 2024. The regions covered in the intravenous therapy solutions market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=25802&type=smp

Browse Through More Reports Similar to the Global Intravenous Therapy Solutions Market 2025, By The Business Research Company

Intravenous Infusion Pumps Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/intravenous-infusion-pumps-global-market-report

Home Infusion Therapy Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/home-infusion-therapy-global-market-report

Clinical Trial Equipment And Ancillary Solutions Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/clinical-trial-equipment-and-ancillary-solutions-global-market-report

About The Business Research Company:

With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Large Is the Intravenous Therapy Solutions Market Expected to Be in 2029?

In recent times, the market size for intravenous therapy solutions has seen a significant rise. The market, which was valued at $11.95 billion in 2024, is predicted to escalate to $13.17 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 10.3%. The expansion during the historical period can be credited to factors such as an increase in hospital admissions, a rise in surgical operations, a growing prevalence of dehydration, a higher incidence of chronic illnesses, and improvements in healthcare infrastructure accessibility.

The market size for intravenous therapy solutions is forecasted to experience a swift expansion in the coming years, ballooning to $19.33 billion in 2029 with a 10.1% Compound Annual Growth Rate (CAGR). The escalation predicted for this period is associated with factors such as the growth in the aging demographic, the broadening of home health care services, an uptick in the need for quick rehydration therapy, a surge in the occurrences of gastrointestinal conditions, and the heightened utilization of disposable IV parts. Key trends during the forecast period encompass advancements in the IV medication delivery mechanisms, a transition towards home-based IV treatment, the incorporation of intelligent infusion pumps, an increase in biological and specialty drug infusions, and a growing inclination towards personalized IV nutritional therapy.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=25802&type=smp

What Are The Contributors To Demand In The Intravenous Therapy Solutions Market?

The intravenous therapy solutions market is predicted to expand due to the rising demand for minimally invasive therapies. These are medical treatments that entail tiny incisions or entry points into the body, often leading to faster recovery and fewer complications. The increasing demand for these therapies is due to their capability to lessen postoperative discomfort, consequently speeding up patient recuperation and enhancing overall comfort during the healing phase. Intravenous therapy solutions bolster minimally invasive treatments by facilitating the effective administration of vital fluids, medicines, and nutrients straight into the bloodstream, thus ensuring top-notch patient care and quicker healing. For example, the American Society of Plastic Surgeons, a non-profit organization based in the US, stated in June 2024 that minimally invasive procedures had risen by 7% in 2023, surpassing surgical procedures by 2%. Thus, the increasing desire for minimally invasive treatments is propelling the intravenous (IV) therapy solutions market’s expansion.

What Segmentation Categories Are Included In The Intravenous Therapy Solutions Market Analysis?

The intravenous therapy solutions market covered in this report is segmented –

1) By Product Type: Crystalloids, Colloids, Blood Products, Other Product Types

2) By Application: Fluid And Electrolyte Imbalance, Nutritional Support, Medication Administration, Blood Transfusion, Other Applications

3) By End-User: Hospitals, Clinics, Ambulatory Surgical Centers, Home Care Settings, Other End-Users

Subsegments:

1) By Crystalloids: Normal Saline (0.9% Sodium Chloride), Half Normal Saline (0.45% Sodium Chloride), Lactated Ringer’s Solution, Dextrose Solutions, Hypertonic Saline

2) By Colloids: Albumin, Dextran, Hydroxyethyl Starch (HES), Gelatin

3) By Blood Products: Packed Red Blood Cells (PRBCs), Platelets, Fresh Frozen Plasma (FFP), Cryoprecipitate

4) By Other Product: Intravenous Immunoglobulins (IVIG), Parenteral Nutrition Solutions, Specialty Intravenous Drugs And Additives

What Upcoming Trends Are Expected To Impact The Intravenous Therapy Solutions Market Globally?

Leading organizations in the intravenous therapy solutions market are concentrating on producing cutting-edge solutions such as ready-to-use drug infusions to improve the effectiveness of treatments and minimize preparation time in clinical environments. The concept of ready-to-use drug infusion pertains to pre-blended, pre-labelled intravenous (IV) medications that are prepared in standard doses and packaging, thereby eliminating the need for compounding or dilution on-site. Take for example, in May 2024, B. Braun Medical Inc., a manufacturing company based in the US, released Levetiracetam in Sodium Chloride Injection, a ready-to-use IV anticonvulsant solution. The product is intended for treating seizures and comes in standardized volumes and concentrations, thus negating the requirement for dilution or compounding at the point of care. The IV formulation of Levetiracetam is pre-mixed in a flexible container, which guarantees precise dosing, diminishes the chance of contamination, and increases convenience for healthcare professionals in emergency and inpatient scenarios.

Who Are The Top-Ranked Companies In The Intravenous Therapy Solutions Market Today?

Major companies operating in the intravenous therapy solutions market are Pfizer Inc., Johnson & Johnson, Otsuka Pharmaceutical Co. Ltd., Baxter International Inc., Fresenius Kabi AG, Grifols S.A., Terumo Corporation, Dr. Reddy’s Laboratories Limited, Sichuan Kelun Pharmaceutical Co. Ltd., Teleflex Incorporated, Hikma Pharmaceuticals PLC, ICU Medical Inc., Biocon Limited, B. Braun Melsungen Aktiengesellschaft, JW Life Science Corporation, AdvaCare Pharma USA, Soxa Formulations & Research Pvt. Ltd., Vifor Pharma Management Ltd., Aetos Pharma Private Limited, LXIR Medilabs Private Limited

Get The Full Report Here:

https://www.thebusinessresearchcompany.com/report/intravenous-therapy-solutions-global-market-report

How Is Intravenous Therapy Solutions Market Adoption Varying Across Different Regions And Sectors?

North America was the largest region in the intravenous therapy solutions market in 2024. The regions covered in the intravenous therapy solutions market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=25802&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model